Related Experiment Video
Updated: Dec 26, 2025
05:10
Purification, Expansion, and Flow Cytometry-Based Phenotyping of Mouse Derived Bone Marrow Mesenchymal Stem Cells
Published on: July 11, 2025
920
Mouse bone marrow mesenchymal stem cells with distinct p53 statuses display differential characteristics
Bo Wang1, Lingxia Wang2, Jiahui Mao3
1Department of Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, P.R. China.
Molecular Medicine Reports
|March 19, 2020
Summary
The tumor suppressor gene p53 influences mesenchymal stem cell (MSC) biology. Loss of p53 in bone marrow MSCs enhances proliferation, differentiation, and migration, offering insights into cancer progression.
Area of Science:
- Stem cell biology
- Cancer biology
- Molecular genetics
Background:
- Mesenchymal stem cells (MSCs) are crucial in tissue repair and tumor microenvironments.
- The p53 tumor suppressor gene regulates cell cycle, apoptosis, and genomic stability.
- p53 is frequently mutated in human cancers, impacting cellular functions.
Purpose of the Study:
- To investigate the role of the p53 gene in the biological characteristics of mouse bone marrow-derived MSCs (mBM-MSCs).
- To analyze how different p53 statuses (wild-type, knockdown, knockout) affect mBM-MSC behavior.
- To explore the implications of p53 function in mBM-MSCs for cancer progression.
Main Methods:
- Generation of mBM-MSCs with varying p53 levels: wild-type (p53+/+), knockdown (p53+/-), and knockout (p53-/-).
- Assessment of cell appearance, surface biomarkers, proliferation rates, differentiation potential (adipogenic, osteogenic), and tumor formation in vivo.
- Analysis of colony formation, migration, stem cell-associated protein expression, microRNA profiles, and secreted factors (TNF-α, IP-10).
Main Results:
- mBM-MSCs with reduced or absent p53 (p53+/- and p53-/-) exhibited increased proliferation, adipogenic, and osteogenic differentiation compared to p53+/+.
- p53 deficiency enhanced colony formation and migratory abilities of mBM-MSCs.
- No tumor formation was observed in vivo across all groups within 3 months.
- Differential expression of specific microRNAs (e.g., increased miR-3152, miR-337; decreased miR-221, miR-155) and proteins (e.g., UBR2, RNF31, MMP19) was noted in p53-deficient mBM-MSCs.
Conclusions:
- p53 plays a significant role in regulating the biological functions of mBM-MSCs.
- Loss of p53 function in mBM-MSCs leads to enhanced proliferative, differentiation, and migratory capacities.
- These findings suggest that p53 status in MSCs could influence cancer progression, warranting further investigation.
Related Concept Videos
02:23Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
01:19Mesenchymal Stem Cells
5.4K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.4K